Evidence map›Paper›PMID 25479617›Full record

Observational studyBMC infectious diseases2014

Burden of herpes zoster-associated chronic pain in Italian patients aged 50 years and over (2009-2010): a GP-based prospective cohort study.

Hélène Bricout, Emilia Perinetti, Paolo Marchettini, Pietro Ragni, Carla Maria Zotti, Giovanni Gabutti, Antonio Volpi, Elisabetta Franco

Open access · goldAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in BMC infectious diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Observational
  11. Article
  12. Impact of Underlying Conditions on Zoster-Related Pain and on Quality of Life Following Zoster.The journals of gerontology. Series A, Biological sciences and medical sciences · 2017
    Observational
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 2 countries.

Hélène BricoutEpidemiological Department, Sanofi Pasteur MSD, Lyon, France. hbricout@spmsd.com.
Emilia PerinettiMedical & Scientific Department, Sanofi Pasteur MSD, Rome, Italy. eperinetti@spmsd.com.
Paolo MarchettiniPain Medicine Center, Hospital San Raffaele of Milan, Milan, Italy. marchettini.paolo@hsr.it.
Pietro RagniLocal Health Authority for Reggio Emilia, Emilia Romagna, Italy. pietro.ragni@ausl.re.it.
Carla Maria ZottiDepartment of Public Health and Paediatrics, University of Turin, Turin, Italy. carla.zotti@unito.it.
Giovanni GabuttiDepartment of Medical Sciences, University of Ferrara, Ferrara, Italy. giovanni.gabutti@unife.it.
Antonio VolpiDepartment of Clinical Sciences, University of Rome Tor Vergata, Rome, Italy. volpi@med.uniroma2.it.
Elisabetta FrancoDepartment of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy. franco@med.uniroma2.it.
University of Rome Tor Vergata · ITSanofi (France) · FRSanofi (Italy) · ITUniversity of Ferrara · ITUniversity of Turin · ITVita-Salute San Raffaele University · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPost-herpetic neuralgia (PHN) is the most common complication in herpes zoster (HZ) patients.

methodsWe performed a longitudinal, prospective study in 108 general practices throughout Italy to assess how many immunocompetent patients aged ≥50 years with newly diagnosed HZ develop HZ-associated pain, its duration and management over 6-months. HZ-associated pain was assessed by a direct question to the patient and by self-assessment of the worst pain felt in the previous two weeks on a visual analogue scale (VAS), a score ≥3 was taken as pain. PHN was defined as pain reported during the study period persisting for ≥3 months. Quality of life (QoL) was measured using the SF-12 questionnaire.

resultsAt enrolment, 370 of the 413 patients (89.6%) reported HZ-associated pain which was still present in 20.6% and 9.2% of patients after three and six months, respectively, despite many patients receiving recommended anti-viral therapy. The overall QoL scores were lower than those in healthy Italians of similar age; scores for patients with HZ-associated pain were lower. The presence of >50 vesicles and VAS score ≥3 at enrolment, and being male were significantly associated with PHN at three months.

conclusionsThese results suggest that HZ and PHN represent an important burden of disease in the elderly. There is a need for interventions that can prevent and reduce the burden of HZ to help improve the quality of life of the elderly. These data may be useful as baseline epidemiology data for the assessment of the impact of the VZV vaccine in Italy, after its implementation.

Indexed as

Quality of LifeAgedChronic PainCohort StudiesFemaleGeneral PracticeHerpes ZosterHerpes Zoster VaccineHumansItalyLongitudinal StudiesMaleMiddle AgedNeuralgia, PostherpeticPain MeasurementProspective StudiesHerpes Zoster Vaccine

Identifiers

PMID25479617
PMCPMC4268902
OpenAlexW2080959769

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.